We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer (PURO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01374789
Recruitment Status : Terminated (The study was terminated due to insufficient recruitment.)
First Posted : June 16, 2011
Last Update Posted : June 3, 2015
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Information provided by (Responsible Party):
WiSP Wissenschaftlicher Service Pharma GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : March 2012
  Study Completion Date : March 2012